Genetic test for heart drug?
Links shared publicly online about this topic.
- 772total visits
Genetic test for heart drug?
View full resource at straitstimes.com
Tags: Heart, Genetic, Drug, Lab Test, Surgery
Most Recently Shared on October 27, 2010 at 3:33 am By:
Genetic test for heart drug?: WASHINGTON - GENETIC testing can help determine whether heart surgery patients benef... http://bit.ly/cUBIoF
Genetic Test Results: Who Wants to Know? - RWJF
rwjf.org — “Research by a Robert Wood Johnson Foundation (RWJF) Health & Society Scholar is at the heart of a groundbreaking, federally-funded study into how genetic testing might affect epilepsy patients and their families.Sara Shostak, PhD, MPH, and Ruth...” View full resource at rwjf.org
Most Recently Shared on April 17, 2012 at 6:20 pm By:
RWJF Human Capital Health Organization
RWJF Scholar's study on #epilepsy asks patients if they or their family would benefit from genetic testing, http://t.co/6gRlB6r1
Bedside Genetic Test to Predict Complications in Cardiac Stent Patients
medgadget.com — “Researchers from the University of Ottawa Heart Institute published the results of a bedside genetic test in The Lancet today. The study demonstrates one” View full resource at medgadget.com
Most Recently Shared on March 30, 2012 at 8:31 pm By:
[News] Bedside Genetic Test to Predict Complications in Cardiac Stent Patients http://t.co/84a0QvA4 #medicaldevice
Panel Recommends More Testing For Obesity Drugs - NYTimes.com
nytimes.com — “An advisory panel of the F.D.A. said obesity drugs should get extra testing to ensure against heart attacks and strokes.” View full resource at nytimes.com
Most Recently Shared on March 29, 2012 at 10:54 pm By:
Panel Recommends More Testing for Obesity Drugs: An advisory panel of the F.D.A. said obesity drugs should get e... http://t.co/CDAGjhRd
Proof-of-Concept for Bedside Rapid Genotyping Test of CYP2C19 - Forbes
forbes.com — “A new point-of-care test can rapidly identify people with a common genetic variant associated with impaired clopidogrel function. The authors claim that this is the first study to demonstrate the feasibility of delivering a genetic test at bedside. In an article published online in the Lancet, Jason Roberts and colleagues report on a new [...]” View full resource at forbes.com
Most Recently Shared on March 29, 2012 at 12:08 am By:
Drugs and Devices OW OW Health
Proof-of-Concept for Bedside Rapid Genotyping Test of CYP2C19: A new point-of-care test can rapidly identi... http://t.co/x1b8y6zi #drug
Merck blood clot drug in limbo after mixed results - chicagotribune.com
chicagotribune.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators, researchers said on Saturday.” View full resource at chicagotribune.com
Most Recently Shared on March 24, 2012 at 7:25 pm By:
Tom Heston, MD Family Medicine Doctor, Physician, and Doctor
Merck blood clot drug in limbo after mixed results - Chicago Tribune http://t.co/WRT7sDEK #health
Merck blood clot drug in limbo after mixed results - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type o” View full resource at news.yahoo.com
Most Recently Shared on March 24, 2012 at 3:52 pm By:
Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/V3CP4aUx
Merck blood clot drug in limbo after mixed results
health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 3:40 pm By:
Merck blood clot drug in limbo after mixed results http://t.co/UqbEmDsV
Merck blood clot drug in limbo after mixed results - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators, researchers said on Saturday. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type o” View full resource at news.yahoo.com
Most Recently Shared on March 24, 2012 at 2:34 pm By:
HealthTrendster Health Executive
Merck blood clot drug in limbo after mixed results - CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding ... http://t.co/CSjRsD5J
Merck blood clot drug in limbo after mixed results | Reuters
reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions” View full resource at reuters.com
Most Recently Shared on March 24, 2012 at 2:30 pm By:
Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but wo... http://t.co/D7llHBd9 #health #news
Merck blood clot drug in limbo after mixed results
health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 2:17 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/pkTWsOfU
Merck blood clot drug in limbo after mixed results
health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regul.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 2:03 pm By:
Jane Anderson Healthy Eating Advisor
Merck blood clot drug in limbo after mixed results http://t.co/vthP4uej
Merck blood clot drug in limbo after mixed results | Reuters
reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers” View full resource at reuters.com
Most Recently Shared on March 24, 2012 at 2:01 pm By:
Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/89kZJOwi
Merck blood clot drug in limbo after mixed results | Reuters
reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions” View full resource at reuters.com
Most Recently Shared on March 24, 2012 at 1:41 pm By:
Richard G. Lanzara Health Professional
Merck blood clot drug in limbo after mixed results http://t.co/zoAe1Rk2 via @reuters #pharma #biotech
Merck blood clot drug in limbo after mixed results | Reuters
reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions” View full resource at reuters.com
Most Recently Shared on March 24, 2012 at 1:39 pm By:
Merck blood clot drug in limbo after mixed results http://t.co/PRRIPy07
Merck blood clot drug in limbo after mixed results | Reuters
reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions” View full resource at reuters.com
Most Recently Shared on March 24, 2012 at 1:38 pm By:
Merck blood clot drug in limbo after mixed results http://t.co/ER6kLZ6C
Advertisement
